1. Circulating non-coding RNAs in chronic kidney disease and its complications
   Anton Jan van Zonneveld et al, 2023, Nature Reviews Nephrology CrossRef
2. miR-379-3p inhibits fat grafting survival and angiogenesis by targeting SOCS1-mediated adipose inflammation
   JingLin Zhu et al, 2024, Electronic Journal of Biotechnology CrossRef
3. Inhibition of circulating exosomes release with GW4869 mitigates severe acute pancreatitis-stimulated intestinal barrier damage through suppressing NLRP3 inflammasome-mediated pyroptosis
   Yang Shao et al, 2024, International Immunopharmacology CrossRef
4. HucMSC exosomes attenuate partial bladder outlet obstruction-induced renal injury and cell proliferation via the Wnt/β-catenin pathway
   Zhaoying Wang et al, 2023, European Journal of Pharmacology CrossRef
5. MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury
   Kenji Tsuji et al, 2023, Diagnostics CrossRef
6. Exosomes Highlight Future Directions in the Treatment of Acute Kidney Injury
   Xiaoyu Zhang et al, 2023, International Journal of Molecular Sciences CrossRef
7. Electroacupuncture Pretreatment Alleviates Cerebral Ischemia-reperfusion Injury by Down-regulating Mir-155-5p
   Xuejing Li et al, 2023, Current Neurovascular Research CrossRef
8. Identification and Validation of Lipid Metabolism Gene FASN-Associated miRNA in Wilms Tumor
   Xiaoqing Wang et al, 2024, Biochemical Genetics CrossRef
9. The role of small extracellular vesicle non-coding RNAs in kidney diseases
   Chuxuan Luo et al, 2022, Frontiers in Genetics CrossRef
10. A quantitative review of nanotechnology‐based therapeutics for kidney diseases
    Hui‐Teng Cheng et al, 2024, WIREs Nanomedicine and Nanobiotechnology CrossRef
11. Islet-resident macrophage-derived miR-155 promotes β cell decompensation via targeting PDX1
    Yan Zhang et al, 2024, iScience CrossRef